Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2020 Filed Jun 25, 2020 00:01 UTC |
HOLMES EDWARD WDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $40.70 | $0.00 |
DisclosureSEC source: 0001193805-20-000744 · e619723_4-holmes.xml · derivative · entry 1 HOLMES EDWARD W · CIK 0001197099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:01 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $40.70 | $0.00 |
DisclosureSEC source: 0001193805-20-000745 · e619724_4-marquet.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| June 22, 2020 Filed Jun 25, 2020 00:02 UTC |
Parschauer Karah HerdmanDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $40.70 | $0.00 |
DisclosureSEC source: 0001193805-20-000746 · e619725_4-parschauer.xml · derivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-21 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| June 12, 2020 Filed Jun 12, 2020 18:22 UTC |
Kummerfeld Keith CSee Remarks
|
PurchaseCommon Stock | 450 | $33.33 | $14,998.50 |
DisclosureSEC source: 0000899243-20-016410 · doc4.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950 Read SEC document |
| June 10, 2020 Filed Jun 10, 2020 21:59 UTC |
SASSINE ANDYDirector · Chief Financial Officer
|
PurchaseCommon Stock | 5,000 | $29.74 | $148,700.00 |
DisclosureSEC source: 0000899243-20-016049 · doc4.xml · nonDerivative · entry 1 SASSINE ANDY · CIK 0001515322 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,245 Read SEC document |
| June 10, 2020 Filed Jun 10, 2020 21:59 UTC |
Payne Joseph EDirector · President and CEO
|
PurchaseCommon Stock | 1,000 | $31.69 | $31,690.00 |
DisclosureSEC source: 0000899243-20-016050 · doc4.xml · nonDerivative · entry 1 Payne Joseph E · CIK 0001727315 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,475,097 F1 · balance_after: 183,137 shares are subject to repurchase by the Company. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:41 UTC |
Ultragenyx Pharmaceutical Inc.Director · 10% owner
|
Exercise / conversionOption (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031641 · doc4.xml · derivative · entry 2 Ultragenyx Pharmaceutical Inc. · CIK 0001515673 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 600,000 shares Expires 2021-06-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2020 Filed May 22, 2020 17:41 UTC |
Ultragenyx Pharmaceutical Inc.Director · 10% owner
|
Exercise / conversionCommon Stock | 600,000 | $16.00 | $9,600,000.00 |
DisclosureSEC source: 0001209191-20-031641 · doc4.xml · nonDerivative · entry 1 Ultragenyx Pharmaceutical Inc. · CIK 0001515673 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:06 UTC |
Kummerfeld Keith CSee Remarks
|
GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005387 · doc4.xml · derivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:02 UTC |
SASSINE ANDYDirector · Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005383 · doc4.xml · derivative · entry 1 SASSINE ANDY · CIK 0001515322 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:31 UTC |
Chivukula PadChief Scientific Officer & COO
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005389 · doc4.xml · derivative · entry 1 Chivukula Pad · CIK 0001727317 · Chief Scientific Officer & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:00 UTC |
Payne Joseph EDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005379 · doc4.xml · derivative · entry 1 Payne Joseph E · CIK 0001727315 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 20:04 UTC |
Hughes Steven GeorgeChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $14.12 | $0.00 |
DisclosureSEC source: 0000899243-20-005386 · doc4.xml · derivative · entry 1 Hughes Steven George · CIK 0001747528 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-02-18 F1 · derivative.exercise_date: 25% of the shares underlying the option vest on the one year anniversary of the date of grant, with the remainder vesting in 36 successive equal monthly increments thereafter. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:45 UTC |
SASSINE ANDYDirector · Chief Financial Officer
|
PurchaseCommon Stock | 5,649 | $9.73 | $54,964.77 |
DisclosureSEC source: 0000899243-19-028803 · doc4.xml · nonDerivative · entry 1 SASSINE ANDY · CIK 0001515322 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,245 F1 · price: The price reported in Column 4 is an average price. These shares were acquired in multiple transactions at prices ranging from $9.70 to $9.75 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price on the Transaction Date. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 21:39 UTC |
SASSINE ANDYDirector · Chief Financial Officer
|
PurchaseCommon Stock | 10,000 | $10.00 | $100,000.00 |
DisclosureSEC source: 0000899243-19-028631 · doc4.xml · nonDerivative · entry 1 SASSINE ANDY · CIK 0001515322 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,596 Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:44 UTC |
BARLOW JAMES FDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026165 · doc4.xml · derivative · entry 1 BARLOW JAMES F · CIK 0001190637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-10-24 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:07 UTC |
FARRELL PETER CDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026109 · doc4.xml · derivative · entry 1 FARRELL PETER C · CIK 0001186102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-10-24 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:17 UTC |
HOLMES EDWARD WDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026123 · doc4.xml · derivative · entry 2 HOLMES EDWARD W · CIK 0001197099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-10-24 F2 · derivative.exercise_date: Shares underlying the options vest monthly over a two year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:17 UTC |
HOLMES EDWARD WDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026123 · doc4.xml · derivative · entry 1 HOLMES EDWARD W · CIK 0001197099 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-10-24 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:12 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026116 · doc4.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-10-24 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:40 UTC |
Parschauer Karah HerdmanDirector
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026159 · doc4.xml · derivative · entry 2 Parschauer Karah Herdman · CIK 0001677455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-10-24 F2 · derivative.exercise_date: Shares underlying the options vest monthly over a two year period from the date of grant. Read SEC document |
| October 25, 2019 Filed Oct 30, 2019 00:40 UTC |
Parschauer Karah HerdmanDirector
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.23 | $0.00 |
DisclosureSEC source: 0000899243-19-026159 · doc4.xml · derivative · entry 1 Parschauer Karah Herdman · CIK 0001677455 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-10-24 F1 · derivative.exercise_date: Shares underlying the options vest monthly over a one year period from the date of grant. Read SEC document |
| September 13, 2019 Filed Sep 18, 2019 01:37 UTC |
Marquet MagdaDirector
|
PurchaseCommon Stock | 2,300 | $10.58 | $24,334.00 |
DisclosureSEC source: 0000899243-19-023769 · doc4.xml · nonDerivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Via Alma Life Sciences, LLC Disclosed balance after: 22,720 Read SEC document |
| September 12, 2019 Filed Sep 12, 2019 21:00 UTC |
Kummerfeld Keith CSee Remarks
|
PurchaseCommon Stock | 500 | $10.69 | $5,346.70 |
DisclosureSEC source: 0000899243-19-023531 · doc4.xml · nonDerivative · entry 1 Kummerfeld Keith C · CIK 0001762749 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| August 29, 2019 Filed Aug 30, 2019 17:00 UTC |
Payne Joseph EDirector · President and CEO · 10% owner
|
PurchaseCommon Stock | 5,000 | $11.22 | $56,100.00 |
DisclosureSEC source: 0000899243-19-022619 · doc4.xml · nonDerivative · entry 1 Payne Joseph E · CIK 0001727315 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,097 F1 · balance_after: Includes 366,274 ordinary shares subject to repurchase pursuant to a Common Stock Purchase Agreement, dated March 4, 2013, as amended on September 27, 2017, by and between the Reporting Person and the Issuer. Read SEC document |
| August 23, 2019 Filed Aug 26, 2019 07:00 UTC |
SASSINE ANDYChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $10.90 | $109,000.00 |
DisclosureSEC source: 0000899243-19-022418 · doc4.xml · nonDerivative · entry 1 SASSINE ANDY · CIK 0001515322 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,596 F1 · price: The price reported in Column 4 is a weighted average price. 1,500 shares were purchased at a price of $10.91 per share, 5,000 shares were purchased at a price of $10.94 per share and 3,500 shares were purchased at a price of $10.85 per share. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 23:51 UTC |
FARRELL PETER CDirector
|
PurchaseCommon Stock | 4,432 | $10.85 | $48,087.20 |
DisclosureSEC source: 0000899243-19-022258 · doc4.xml · nonDerivative · entry 2 FARRELL PETER C · CIK 0001186102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 42,955 F2 · price: The price reported in Column 4 is a weighted average price. 4,100 shares were purchased at a price of $10.86 per share and 332 shares were purchased at a price of $10.72 per share. F1 · ownership.nature: By Peter C. Farrell Trust. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 23:51 UTC |
FARRELL PETER CDirector
|
PurchaseCommon Stock | 4,681 | $11.02 | $51,584.62 |
DisclosureSEC source: 0000899243-19-022258 · doc4.xml · nonDerivative · entry 1 FARRELL PETER C · CIK 0001186102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 38,523 F1 · ownership.nature: By Peter C. Farrell Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.